Since alkylamide D (Dodeca-2E,4E-Dienoic acid isobutylamide) had significant antiviral activity against both the rhinovirus and the influenza virus and inhibited IL-8 secretion, this alkylamide has potential for use as a therapeutic for these infections. The gene discussed is CXCL8; the disease is infection.